Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Gastroenterology

Journal Scan / Research · November 11, 2021

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use and Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

The American Journal of Gastroenterology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Abdul Haseeb MD

The American Journal of Gastroenterology

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

Am. J. Gastroenterol 2021 Oct 19;[EPub Ahead of Print], ML Ramsey, Y Gokun, LA Sobotka, MR Wellner, K Porter, SE Kirkby, SS Li, GI Papachristou, SG Krishna, PP Stanich, PA Hart, DL Conwell, LF Lara

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use and Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

Additional Info

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis

Further Reading

Duodenal Papilla Radiomics–Based Prediction Model for Post–ERCP Pancreatitis Using Machine Learning

Genetic Risk Accentuates the Effects of Diet on Hepatic Steatosis, Inflammation, and Fibrosis

First-Time ERCP for Benign Indications More Than 1 Year After Cholecystectomy: Incidence and Outcomes

Characterization of the Gut Microbiota and Mycobiota in Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis

Clinical Presentation and Spectrum of Gluten Symptomatology in Celiac Disease

Gut-Associated Lymphoid Tissue Attrition Is Associated With Response to Anti-α4β7 Therapy in Patients With Ulcerative Colitis

A Cross-Institution Protocol for Virtual, Transdiagnostic, Group Gut-Directed Hypnotherapy

Optimal Glycaemic Control and the Reduced Risk of Colorectal Adenoma and Cancer in Patients With Diabetes

Performance of Noninvasive Tests for Portal Hypertension vs Hepatic Venous Pressure Gradient in Predicting the Risk of Hepatic Decompensation

Validation of the AGA Clinical Care Pathway and the AASLD Practice Guidance for NAFLD in a Cohort of Patients With Type 2 Diabetes

Determinants of Clinical Response to Empirical Antibiotic Treatment in Patients With Cirrhosis and Bacterial and Fungal Infections

Recently Updated